ZNF552 Activators
ZNF552 can initiate a cascade of intracellular events leading to its activation through various signaling pathways. Forskolin is known to activate adenylate cyclase, which subsequently increases cAMP levels within the cell. Elevated cAMP can activate protein kinase A (PKA), a kinase that plays a central role in phosphorylating various proteins, including transcription factors like ZNF552. By phosphorylating ZNF552, PKA can alter its conformation or interaction with other molecules, thereby enhancing its DNA-binding activity. Similarly, Dibutyryl-cAMP, a synthetic analogue of cAMP, can also activate PKA, suggesting a parallel mechanism for the activation of ZNF552. In addition to cAMP-mediated pathways, phorbol 12-myristate 13-acetate (PMA) and 12-O-Tetradecanoylphorbol-13-acetate (TPA) are potent activators of protein kinase C (PKC). PKC phosphorylates a plethora of substrates, which can include transcription factors like ZNF552, thereby potentially influencing ZNF552's activity.
Ionomycin, by increasing intracellular calcium levels, can activate calmodulin-dependent kinases, which are capable of phosphorylating transcription factors and could do so with ZNF552. Epidermal Growth Factor (EGF) activates its receptor, initiating the MAPK/ERK pathway, which is known for its role in the phosphorylation of transcription factors, suggesting a possible avenue for ZNF552 activation. Furthermore, insulin, through its receptor, can stimulate the PI3K/AKT signaling pathway, leading to a cascade of phosphorylation events that can include the modification of ZNF552. Lithium chloride's inhibition of GSK-3 can result in increased β-catenin levels, which may interact with and influence the activity of ZNF552. Retinoic acid, acting on its nuclear receptors, can affect the gene expression landscape, which may include modulating the activity of ZNF552. Lastly, histone deacetylase inhibitors such as Trichostatin A and Sodium butyrate can alter chromatin structure, potentially affecting the accessibility of DNA binding sites for ZNF552 and influencing its activation state.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate and thereby regulate transcription factors, potentially including ZNF552, resulting in its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentrations, activating calmodulin-dependent kinases, which could phosphorylate and activate ZNF552. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor leading to PI3K activation and subsequent AKT signaling, which could result in the phosphorylation and activation of ZNF552 through downstream effects on transcription factor dynamics. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA. PKA can then phosphorylate substrates including transcription factors like ZNF552, resulting in activation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, leading to increased β-catenin levels, which may interact with and activate transcription factors including ZNF552 by promoting their stabilization and nuclear localization. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts on its nuclear receptors which can heterodimerize with other transcription factors and influence gene expression, potentially activating ZNF552 by affecting its ability to bind DNA. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases like JNK, which may activate ZNF552 through phosphorylation and regulation of transcription factor activity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which can alter chromatin structure and gene expression, potentially leading to the activation of ZNF552 by changing the accessibility of the DNA it binds to. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, another histone deacetylase inhibitor, can also affect chromatin structure, possibly resulting in the activation of ZNF552 through enhanced DNA binding or interaction with other transcriptional regulators. | ||||||